We use cookies to ensure that we give you the best experience on our website. If you click accept my preferences we'll assume that you are happy to receive all cookies on our website. Visit our Cookie Policy and our Privacy Policy for more information about managing your cookies.

Current preferences

Using the non-VKA oral antagonists: What does the ‘real-world’ evidence tell us? - GM Conference 2016

Professor Robinson explains what ‘real-world’ evidence tell us regarding the use of non-VKA oral antagonists from The GM Conference 2016.



Register with GM to watch the full video.


It takes less than a minute, it doesn't cost anything, and you'll get instant access.


Already a member? Log in below.